+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Apoptosis"

FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2024 - Product Thumbnail Image

FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
From
Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-akt inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
STAT Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
Transforming growth factor beta inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Transforming growth factor beta inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
4-1BB receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

4-1BB receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c mdm2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
TRAIL receptor 2 agonists - Pipeline Insight, 2024 - Product Thumbnail Image

TRAIL receptor 2 agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene protein c-myc inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 96 Pages
  • Global
From
Proto oncogene proteins c pim 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto oncogene proteins c pim 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proto-oncogene protein c-bcl-2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
P53 Antigen Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

P53 Antigen Modulators - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Proteasome inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proteasome inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Inhibitor Of Apoptosis (IAP) Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Inhibitor Of Apoptosis (IAP) Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Apoptosis Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Apoptosis Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

Apoptosis is a form of programmed cell death that is essential for the normal development and functioning of multicellular organisms. In biotechnology, apoptosis is a key area of research and development, as it is involved in a variety of diseases and conditions. Apoptosis-related research is focused on understanding the molecular mechanisms of cell death, as well as developing drugs and therapies that can modulate the process. This includes the development of drugs that can induce apoptosis in cancer cells, as well as drugs that can inhibit apoptosis in other diseases. The apoptosis market is a rapidly growing segment of the biotechnology industry, with a wide range of products and services available. Companies in the market are focused on developing drugs and therapies that can modulate the process of apoptosis, as well as providing research and development services related to apoptosis. Examples of companies in the apoptosis market include ApoGen Biotechnologies, ApoPharma, ApoThera, and ApoTek. Show Less Read more